Inventor
ADAMS CHRISTOPHER M
US19 patents
⚠️ This page may combine multiple inventors who share the name “ADAMS CHRISTOPHER M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV IOWA RES FOUND
6 patentsUS9254295B2Feb 9, 2016
Tomatidine, analogs thereof, compositions comprising same, and uses for same
UNIV IOWA RES FOUND27 citations91
US10137136B2Nov 27, 2018
Methods for inhibiting muscle atrophy
UNIV IOWA RES FOUND6 citations82
US11090313B2Aug 17, 2021
Methods for inhibiting muscle atrophy
UNIV IOWA RES FOUND4 citations71
US10668087B2Jun 2, 2020
Methods for inhibiting muscle atrophy
UNIV IOWA RES FOUND1 citations71
US10576091B2Mar 3, 2020
Tomatidine, analogs thereof, compositions comprising same, and uses for same
UNIV IOWA RES FOUND1 citations70
US10022386B2Jul 17, 2018
Tomatidine, analogs thereof, compositions comprising same, and uses for same
UNIV IOWA RES FOUND1 citations60
ADAMS CHRISTOPHER M
5 patentsUS9295664B2Mar 29, 2016
Methods for lowering blood glucose
ADAMS CHRISTOPHER M17 citations89
US9856204B2Jan 2, 2018
Methods for inhibiting muscle atrophy
ADAMS CHRISTOPHER M5 citations66
US10208018B2Feb 19, 2019
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators
ADAMS CHRISTOPHER M0 citations48
US9765067B2Sep 19, 2017
Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
ADAMS CHRISTOPHER M0 citations38
US9957254B2May 1, 2018
Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
ADAMS CHRISTOPHER M0 citations36
NOVARTIS AG
4 patentsUS10751417B2Aug 25, 2020
Sustained release delivery systems comprising traceless linkers
NOVARTIS AG11 citations82
US12433949B2Oct 7, 2025
Sustained release delivery systems comprising traceless linkers
NOVARTIS AG0 citations59
US10550102B2Feb 4, 2020
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators
NOVARTIS AG0 citations49
US11389541B2Jul 19, 2022
Sustained delivery of angiopoetin-like 3 polypeptides
NOVARTIS AG0 citations44